Stay updated on Donafenib & KN046 Combo in GI Tumors Clinical Trial
Sign up to get notified when there's something new on the Donafenib & KN046 Combo in GI Tumors Clinical Trial page.

Latest updates to the Donafenib & KN046 Combo in GI Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page's revision indicator was updated to v3.5.4, replacing the previous v3.5.3, signaling a small update to the page metadata.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe study record now shows Terminated with the reason 'Due to R&D strategy adjustments; no safety issues involved,' with updated dates (2026-05-01 and 2026-04-27). It also adds sections for Study Status, Contacts/Locations, and Study Design, and removes older labels like Recruiting and the prior last-known status details.SummaryDifference2%

- Check26 days agoChange DetectedThe page’s “Revision” version was updated (v3.5.2 → v3.5.3), reflecting a general platform/software update rather than a change to the clinical trial record content.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision history shows an addition of Revision: v3.5.2 and a deletion of Revision: v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record history shows a new revision entry (v3.5.0) and removal of an earlier revision (v3.4.3).SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, and the previous entry v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Donafenib & KN046 Combo in GI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Donafenib & KN046 Combo in GI Tumors Clinical Trial page.